Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2023 03:00 ET | Source: MitoRx Therapeutics

MitoRx Therapeutics Announces Scientific Advisory Board, Chief Development Officer and Finance Director

OXFORD, England, March 07, 2023 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing revolutionary therapeutics that reverse mitochondrial dysfunction to arrest the...
June 04, 2019 07:00 ET | Source: Guardion Health Sciences, Inc.

Guardion Launches Second Ocular Health Formula ‘GlaucoCetin’

In an IRB-approved trial conducted at the New York Eye and Ear Infirmary, the parent compound of GlaucoCetin, GlaucoHealth, designed by Robert Ritch, MD, successfully reversed mitochondrial...